Haleon (NYSE:HLN) Cut to Equal Weight at Morgan Stanley

Morgan Stanley downgraded shares of Haleon (NYSE:HLN) from an overweight rating to an equal weight rating in a research report sent to investors on Friday morning, MarketBeat.com reports.

Several other research firms have also commented on HLN. UBS Group upgraded Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $10.95.

Haleon Trading Down 4.0 %

Shares of HLN opened at $9.11 on Friday. The stock has a market cap of $41.24 billion, a PE ratio of 26.79, a price-to-earnings-growth ratio of 2.95 and a beta of 0.29. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon has a 52-week low of $7.89 and a 52-week high of $10.80. The firm’s fifty day moving average is $9.59 and its two-hundred day moving average is $9.69.

Hedge Funds Weigh In On Haleon

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Fortitude Family Office LLC acquired a new stake in Haleon in the third quarter valued at $28,000. Versant Capital Management Inc increased its position in Haleon by 2,029.1% in the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock valued at $34,000 after acquiring an additional 3,348 shares during the period. Toronto Dominion Bank raised its stake in shares of Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after purchasing an additional 3,470 shares during the last quarter. Prospera Private Wealth LLC purchased a new position in Haleon during the 3rd quarter worth $57,000. Finally, BOKF NA lifted its position in Haleon by 68.8% in the second quarter. BOKF NA now owns 6,972 shares of the company’s stock valued at $58,000 after purchasing an additional 2,842 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.